JPRN-UMIN000020631
Recruiting
未知
Safety and efficacy of postoperative adjuvant chemotherapy with L-OHP base regimen followed by UFT plus LV for resectable liver metastases from colorectal cancer - Safety and efficacy of postoperative adjuvant chemotherapy with L-OHP base regimen followed by UFT plus LV for resectable liver metastases from colorectal cancer (LOFT trial)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- resectable liver metastases from colorectal cancer
- Sponsor
- Kyoto University
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Neurologic symptom due to cerebrovascular diseases. 2\. Cardiac diseases. 3\. Uncontrollable hypertension, Uncontrollable diabetes. 4\. Renal dysfunction. 5\. Uncontrollable gastrointestinal ulcer 6\. Prior hypersensitivity reaction to drugs used in this trial. 7\. Suspected of DPD Deficiency. 8\. Prior treatment with L\-OHP within 6 months. 9\. Treatment with MTX to RA. 10\. Uncontrollable infectious diseases. 11\. Uncontrollable diarrhea. 12\. Neuropathy \>\= Grade2 according to the CTCAE. 13\. Body fruid (ascites,pleural effusion.pericardiac effsion). 14\. Multiple malignancies to be treated within 5 years. 15\. Prior treatment with immunosuppressant and transplantation. 16\. Pregnant. 17\. Any other cases who are regarded as inadequate for study enrollment by investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
OFT trialColorectal liver metastasisCRLM, FOLFOXJPRN-jRCT1051190106Hatano Etsuro50
Not yet recruiting
Not Applicable
sefulness of postoperative adjuvant chemotherapy in patients with colorectal cancer T1/T2, N(+)colon cancerJPRN-UMIN000047044Japanese Foundation for Multidisciplinary Treatment of Cancer621
Active, not recruiting
Phase 1
Study to evaluate the benefit and safety of a drug, paclitaxel, in the treatment of advanced ovarian cancer by applying intraperitoneally for three hours a day in the days following surgery, in which disease malignant ovarian tumor was removed and chemotherapy was administered hyperthermic intraoperative intraperitoneally.EUCTR2014-002850-38-ESFUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DE CÓRDOBA60
Completed
Not Applicable
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
Completed
Not Applicable
Feasibility study of a postoperative adjuvant chemotherapy which performs the maintenance therapy of TS-1 after CBDCA+TS-1 to the patients of pathological stage II-IIIA with completely resected non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000006351Escargot40